Immunomax, lyophilizate 200 units 3 pcs

Pharmacotherapeutic group: immunomodulatory agent

Pharmacological properties

.Pharmacodynamics

Immunomax enhances immune protection against viral and bacterial infections.

The immunopharmacological mechanisms of action of the drug are that

Immunomax activates the following links of the immune system:

• NK cells, which, 2-3 hours after exposure to Immunomax, are enhanced

express CD69 activation molecules. The cytolytic activity of NK cells

increases 3-fold;

• circulating monocytes 2-4 hours after activation by Immunomax

start secreting cytokines: interleukin-8, interleukin-1b, and necrosis factor

tumor alpha;

• neutrophil granulocytes are activated through monocytes,

the drug has no direct effect on neutrophil granulocytes.

The monocyte-secreted interleukin-8 causes activation of neutrophilic

Granulocytes, which is clearly seen 24 hours after exposure

Immunomax;

• tissue macrophages, which is manifested by changes in the morphology of these cells,

increased production of bactericidal substances, changes in the activity

5′-nucleotidase;

• formation of antibodies against foreign antigens, soluble and corpuscular;

Immunomax enhances protection against infections caused by viruses (human papilloma virus

Human papillomavirus, herpes simplex virus, parvovirus, flesh-eating plague virus, etc.) or

bacteria (E. coli, salmonella, staphylococcus, chlamydia, mycoplasma,

reaplasma, etc.). This effect of the drug is manifested in adults and newborns when

Immunomax is administered in different ways: intramuscularly, intravenously,

intraperitoneally, per os.

Pharmacokinetics of the drug has not been studied due to its peptidoglycan nature and

very low potent doses.

Indications

Human papilloma virus

Active ingredient

Composition

How to take, the dosage

The drug is dissolved in 1 ml of water for injection before use.
The recommended dose for adults and children 12 years and older is 100-200 units depending on the severity of the disease. The drug is administered intramuscularly once a day.
Treatment course is 6 injections on the 1st, 2nd, 3rd, 8th, 9th, 10th days of treatment.
The course of treatment of recurrent anogenital warts is divided into 6 injections in 200 units each.
Immunomax is combined with the destruction of warts using one of the standard methods:
cryodestruction, electrocoagulation, laser destruction or solcoderm.
For the treatment of infections caused by bacteria or viruses the course of 3-6 injections of 100-200 IU of Immunomax is made
6 injections;
For the correction of weakened immunity the course of 3-6 injections of 100-200 IU of Immunomax is made
.

Special Instructions

Information about possible effect on ability to operate vehicles, machinery

The drug does not affect the ability to operate vehicles, moving machinery and other potentially dangerous activities that require high levels of concentration and psychomotor reaction.

Synopsis

Contraindications

Side effects

Overdose

Pregnancy use